- Home
- CMMB vs NXGL Comparison
CMMB vs NXGL Comparison
Compare CMMB & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMMB | NXGL |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | Israel | United States |
| Employees | N/A | 19 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 9.8M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMMB | NXGL |
|---|---|---|
| Price | $1.58 | $0.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $25.00 | $2.00 |
| AVG Volume (30 Days) | 47.1K | ★ 241.2K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $39.28 |
| Revenue Next Year | N/A | $42.29 |
| P/E Ratio | $39.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $0.58 |
| 52 Week High | $3.86 | $3.02 |
Technical Indicators
Market Signals| Indicator | CMMB | NXGL |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 28.69 |
| Support Level | $1.48 | N/A |
| Resistance Level | $1.64 | $1.76 |
| Average True Range (ATR) | 0.18 | 0.07 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 14.00 | 4.58 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.